Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$216,771,755
-$50,060,201 QoQ
Shares Held
861,436
-29.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#148
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names. ABBV ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,771,755 | 861,436 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $266,831,956 | 1,226,870 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $459,947,628 | 2,012,988 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $473,398,117 | 2,044,563 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $399,826,593 | 2,154,006 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $444,688,600 | 2,122,416 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $365,953,425 | 2,059,389 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $400,823,576 | 2,029,692 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $355,715,499 | 2,073,901 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $382,889,651 | 2,102,634 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $306,158,732 | 1,975,600 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $348,291,360 | 2,336,585 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $244,053,963 | 1,811,430 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $404,551,023 | 2,538,439 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $463,745,228 | 2,869,533 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $380,369,124 | 2,834,134 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $563,083,550 | 3,676,440 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $543,106,433 | 3,350,234 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $369,182,317 | 2,726,605 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $242,956,032 | 2,252,304 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $193,931,386 | 1,721,692 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $174,724,436 | 1,614,530 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $166,912,591 | 1,557,747 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $75,036,426 | 856,678 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $68,736,701 | 700,109 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $28,737,953 | 377,188 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||